Patients
7.9 per 100,000 people
Suicide rate, China, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
China Stress Relief Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$368.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $279.3 Mn | — | — |
| 2025 (base) | $305.0 Mn | +$25.7 Mn | — |
| 2026 (forecast) | $333.1 Mn | +$28.1 Mn | +9.2% |
| 2027 (forecast) | $363.7 Mn | +$30.6 Mn | +19.2% |
| 2028 (forecast) | $397.2 Mn | +$33.5 Mn | +30.2% |
| 2029 (forecast) | $433.7 Mn | +$36.5 Mn | +42.2% |
| 2030 (forecast) | $473.7 Mn | +$39.9 Mn | +55.3% |
| 2031 (forecast) | $517.2 Mn | +$43.6 Mn | +69.6% |
| 2032 (forecast) | $564.8 Mn | +$47.6 Mn | +85.2% |
| 2033 (forecast) | $616.8 Mn | +$52.0 Mn | +102.2% |
| 2034 (forecast) | $673.5 Mn | +$56.7 Mn | +120.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $305.0 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $673.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Ingredient, form and distribution channel (see all) |
| Key players | Olly (Unilever), Natrol LLC, Nature’s Bounty, Goli Nutrition, Himalaya Wellness (see all) |
| Regulator in China | NMPA and SAMRSource: National Medical Products Administration. Checked 14 Nov 2026.Source: State Administration for Market Regulation. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Stress relief supplements contain ingredients such as ashwagandha, magnesium, L-theanine and herbal blends marketed to ease stress and support calm.
Key segments of the stress Relief Supplements market include ingredient (Ashwagandha, Magnesium and L-Theanine) and form (Capsules, Gummies and Powders).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the stress Relief Supplements market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the stress Relief Supplements market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the stress Relief Supplements market.
The stress Relief Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drugs need approval from the National Medical Products Administration (NMPA) before sale.[1] Health foods, sold with a blue-hat logo, must be registered or filed with the State Administration for Market Regulation (SAMR).[2] Suicide rate: 7.9 per 100,000 people in 2023, the latest WHO figure for China.[3]
[1] National Medical Products Administration. Checked 14 Nov 2026.
[2] State Administration for Market Regulation. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern stress Relief Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in China.
What doctors and scientists are doing in Stress Relief Supplements right now, from free public sources.
7.9 per 100,000 people
Suicide rate, China, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
China · 5 shared keywords
China · 5 shared keywords
China · 4 shared keywords
China · 4 shared keywords
China · 4 shared keywords
China · 4 shared keywords
Pharmaceuticals · China
Digital Health · China
Digital Health · China
Pharmaceuticals · China
Pharmaceuticals · China
Healthcare Services · China